Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-30 Sale |
2020-12-01 7:13 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
10,393 | $33.15 | $344,513 | 6,062,813 (Indirect Direct) |
View |
| 2020-11-19 Sale |
2020-11-23 4:41 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
130,017 | $33.01 | $4,291,861 | 7,646,829 (Indirect Direct) |
View |
| 2020-11-17 Sale |
2020-11-19 9:19 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
4,730 | $33.05 | $156,349 | 7,776,846 (Indirect Direct) |
View |
| 2020-11-13 Sale |
2020-11-17 7:33 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
4,700 | $33.74 | $158,587 | 7,781,576 (Indirect Direct) |
View |
| 2020-11-12 Sale |
2020-11-13 7:47 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
15,598 | $34.15 | $532,642 | 6,937,033 (Indirect Direct) |
View |
| 2020-11-10 Sale |
2020-11-12 5:41 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
39,583 | $34.11 | $1,350,354 | 8,751,874 (Indirect Direct) |
View |
| 2020-11-06 Sale |
2020-11-10 7:24 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
9,400 | $33.08 | $310,949 | 8,791,457 (Indirect Direct) |
View |
| 2020-11-04 Sale |
2020-11-06 4:44 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
11,348 | $33.14 | $376,127 | 8,800,857 (Indirect Direct) |
View |
| 2020-10-26 Sale |
2020-10-28 5:58 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
8,903 | $33.28 | $296,293 | 8,812,205 (Indirect Direct) |
View |
| 2020-10-15 Sale |
2020-10-20 8:09 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
15,746 | $33.44 | $526,529 | 8,821,108 (Indirect Direct) |
View |
| 2020-10-20 Purchase |
2020-10-20 4:58 pm |
Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner |
200,000 | $15 | $3,000,000 | 3,292,339 (Indirect Direct) |
View |
| 2020-10-13 Sale |
2020-10-15 7:22 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
17,240 | $33.3 | $574,015 | 8,836,854 (Indirect Direct) |
View |
| 2020-10-08 Sale |
2020-10-13 7:41 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
22,625 | $33.5 | $757,924 | 8,854,094 (Indirect Direct) |
View |
| 2020-10-06 Sale |
2020-10-08 7:14 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
45,926 | $33.44 | $1,535,732 | 6,056,892 (Indirect Direct) |
View |
| 2020-08-10 Sale |
2020-08-12 7:57 pm |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
13,792 | $33.06 | $455,989 | 10,541,469 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-11-27 Other |
2020-12-01 7:13 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
440,782 | $0 | 6,062,813 (Direct) |
View |
| 2020-11-23 Other |
2020-11-25 4:49 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
788,828 | $0 | 5,151,052 (Direct) |
View |
| 2020-11-11 Other |
2020-11-13 7:47 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
984,298 | $0 | 6,937,033 (Direct) |
View |
| 2020-10-20 Conversion |
2020-10-20 4:58 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner |
3,092,339 | $0 | 3,292,339 (Direct) |
View |
Ownership |
2020-10-15 5:16 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner |
0 | $0 | 3,092,339 (Direct) |
View |
| 2020-10-07 Other |
2020-10-08 7:14 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
299,051 | $0 | 6,056,892 (Indirect) |
View |
| 2020-09-17 Other |
2020-09-21 7:28 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
754,743 | $0 | 6,569,238 (Direct) |
View |
| 2020-08-18 Other |
2020-08-20 6:13 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
311,176 | $0 | 10,263,821 (Direct) |
View |
| 2020-08-12 Other |
2020-08-14 5:55 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
311,176 | $0 | 10,563,821 (Direct) |
View |